Itsik Ben-Dor

Showing 1-7 of 7 articles

Interventions for valvular disease

The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement

Kiramijyan S, Magalhaes M, Ben-Dor I, Koifman E, Escarcega R, Baker N, Torguson R, Okubagzi P, Bernardo N, Satler L, Pichard A, Waksman R

May 16, 2016 | 10.4244/EIJV12I1A16

Usefulness of combined intravascular ultrasound parameters to predict functional significance of coronary artery stenosis and determinants of mismatch

Cho Y-K, Nam C, Han J-K, Koo B, Doh J, Ben-Dor I, Waksman R, Pichard A, Murata N, Tanaka N, Lee C-H, Gonzalo N, Escaned J, Costa M, Kubo T, Akasaka T, Hu X, Wang J-A, Yang H-M, Yoon M-H, Tahk S, Yoon H-J, Chung I-S, Hur S-H, Kim K-B

June 19, 2015 | 10.4244/EIJV11I2A30

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis

Ben-Dor I, Torguson R, Gaglia M, Gonzalez M, Maluenda G, Bui A, Xue Z, Satler L, Suddath W, Lindsay J, Pichard A, Waksman R

June 30, 2011 | 10.4244/EIJV7I2A37

Impact of drug-eluting stent type on periprocedural myocardial necrosis

Wakabayashi K, Delhaye C, Mahmoudi M, Belle L, Ben-Dor I, Gaglia M, Suddath W, Satler L, Kent K, Pichard A, Lindsay J, Waksman R

May 17, 2011 | 10.4244/EIJV7I1A22

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

Lemesle G, Torguson R, Bonello L, de Labriolle A, Maluenda G, Ben-Dor I, Collins S, Syed A, Xue Z, Satler L, Pichard A, Waksman R

April 20, 2011

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention

Syed A, Ben-Dor I, Li Y, Collins S, Torguson R, Wakabayashi K, Gonzalez M, Maluenda G, Delhaye C, Belle L, Gaglia M, Jr. J, Xue Z, Kaneshig K, Bernardo N, Kent K, Suddath W, Satler L, Pichard A, Lindsay J, Waksman R

April 20, 2011

Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions

Assali A, Raz Y, Vaknin-Assa H, Ben-Dor I, Brosh D, Teplitsky I, Fuchs S, Kornowski R

May 13, 2008

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease